表紙
市場調查報告書
商品編碼
1082803

節肢動物媒介性病毒傳染病檢查的全球市場:2022年∼2029年

Global Arthropod borne Viral Infections Testing Market - 2022-2029

出版日期: | 出版商: DataM Intelligence | 英文 190 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球節肢動物媒介性病毒傳染病檢查的市場調查,彙整市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素的分析,法律制度,市場規模的轉變·預測,各種區分·地區/各主要國家的明細,競爭環境,主要企業簡介等資訊。

目錄

第1章 全球節肢動物媒介性病毒傳染病檢查市場:調查手法·調查範圍

第2章 全球節肢動物媒介性病毒傳染病檢查市場:市場定義和概要

第3章 全球節肢動物媒介性病毒傳染病檢查市場:摘要整理

第4章 全球節肢動物媒介性病毒傳染病檢查市場:市場動態

  • 影響市場的要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 全球節肢動物媒介性病毒傳染病檢查市場:產業分析

  • 波特的五力分析
  • 供應鏈分析
  • 法規分析

第6章 全球節肢動物媒介性病毒傳染病檢查市場:COVID-19分析

  • COVID-19:對市場的影響分析
  • COVID-19風暴中的價格動態
  • 供需頻譜
  • 政府在COVID-19疫情下的市場相關措施
  • 製造商的策略性舉措
  • 總論

第7章 全球節肢動物媒介性病毒傳染病檢查市場:檢驗各類型

  • ELISA為基礎的檢驗
  • RT-PCR為基礎的檢驗
  • 其他

第8章 全球節肢動物媒介性病毒傳染病檢查市場:各疾病類型

  • 登革熱
  • 屈公病
  • 聖路易斯腦炎
  • 黃熱病
  • 加利福尼亞腦炎
  • 東部馬腦炎
  • Powassan
  • West Nile
  • 茲卡

第9章 全球節肢動物媒介性病毒傳染病檢查市場:各終端用戶

  • 醫院
  • 研究中心
  • 診斷中心
  • 其他

第10章 全球節肢動物媒介性病毒傳染病檢查市場:各地區

  • 北美
  • 歐洲
  • 南美
  • 亞太地區
  • 中東·非洲

第11章 全球節肢動物媒介性病毒傳染病檢查市場:競爭情形

  • 主要的展開·展與策略
  • 企業佔有率分析
  • 產品基準

第12章 全球節肢動物媒介性病毒傳染病檢查市場:企業簡介

  • Bio Techne
  • Agilent Technologies
  • ThermoFisher Scientific
  • NovaTecImmundiagnostica
  • Euroimmun AG
  • Abbott Laboratories
  • Bio-Rad
  • Merck
  • Acrobiosystems
  • Biotechne
  • Elabscience

第13章 全球節肢動物媒介性病毒傳染病檢查市場:DataM

目錄
Product Code: DMCD5239

Market Overview

The global arthropod borne viral infections testing market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX% during the forecast period (2022-2029).

California encephalitis, Chikungunya, dengue, Eastern equine encephalitis, Powassan, St. Louis encephalitis, West Nile, Yellow Fever, and Zika are examples of arboviral diseases spread among humans by the bite of infected arthropods (insects) such as mosquitoes and ticks. Other diseases spread by infected arthropods' bites that aren't viral infections, such as Lyme disease (a bacterial infection) and babesiosis (a parasitic infection), aren't arboviral. These diseases usually appear during the summer months, when mosquitoes and ticks are busy. Arboviral infection appears to be more common in young children and the elderly.

Market Dynamics

Increased frequency of numerous arbovirus illnesses is a major element affecting the arthropod-borne viral infections market. This would assist the market is gaining traction in the next years. In addition, rising healthcare spending is expected to drive the industry in the upcoming years.

Increasing nmber of initiatives taken by the government will drive the market growth

To reduce the danger of arthropod-borne viral infections, governments worldwide are collaborating with health groups. With significant outbreaks being reported worldwide in recent years, the focus on these diseases has increased as a matter of public safety. The development of coronavirus in 2020 has emphasized the significance of government participation in public health issues. For example, in 2022, Global New Infections Surveillance (GEIS), a part of the United States Armed Forces Health Surveillance Branch, will undertake a pilot program to identify emerging infectious diseases and decrease risk. A global laboratory network to improve global health security is projected to do this.

Rise in the number of cases of encephalitis would aid the growth of the arthropod-borne viral diseases market during the forecast period. According to World Health Organization estimates from 2019, the Japanese encephalitis virus (JEV) is one of the most common causes of viral encephalitis in Asian countries, causing 68,000 clinical cases each year. Furthermore, the mortality rate among patients suffering from encephalitis has been as high as 30%. In addition, the JEV can have various adverse effects, such as long-term neurologic or psychological consequences. This may affect 30-50% of the patient population. The market for arthropod-borne viral infections is expected to grow in the next years as the number of molecular diagnostic approaches for identifying the illness grows. For example, Co-Diagnostics, Inc. announced in October 2019 that a diagnostic approach for detecting the encephalitis virus would be available in 2020. This is a biotech firm with a proprietary platform for molecular diagnostic test development. The test for eastern equine encephalitis (EEE) is expected to be ready in time for the 2020 mosquito season. The bulk of the civil populace is likely to pay attention to increased R&D to develop diagnostic tools for identifying possible encephalitis viruses.

Lack of awareness about infectious diseases is likely to hamper the market growth

However, lack of awareness about several infectious diseases may limit the growth of the arthropod-borne viral infections market.

COVID-19 Impact Analysis

In collaboration with governments around the world, pharmaceutical and biotech businesses are working to tackle the COVID-19 outbreak, from vaccine research to overcoming supply chain hurdles. In the R&D pipeline, there are around 115 vaccine candidates and another 155 compounds. Furthermore, routinely used medications, such as hydroxychloroquine, have significantly increased the demand for COVID-19 treatment. Furthermore, demand for COVID-19 management pharmaceuticals has increased, which is projected to present a significant opportunity for drug producers, as many developed countries need these medications. The pharmaceutical and biotechnology industries are expected to increase significantly in the next years due to the growing demand for COVID-19 vaccines and treatment medications.

Segment Analysis

The RT-PCR based tests segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

Based on test type, it is bifurcated into ELISA-based tests and RT-PCR based tests. The RT-PCR based tests segment dominated the global market in 2020 and is anticipated to continue this trend during the forecast period because of its advantages, the RT-PCR-based tests segment is likely to dominate the arbovirus testing market over the forecast period. The detection limit is a fundamental distinction between ELISA (Enzyme-linked immunosorbent assay) and PCR assays. An ELISA-based method typically has a detection limit of 104-106 CFU/ml, but a PCR method can detect in the 103 CFU/ml range. Because of the difference in detection limits, an ELISA approach normally requires a longer enrichment time. Even in terms of sensitivity, the PCR approach outperforms the ELISA technique. Compared to ELISA, the waste produced in laboratories using the PCR technique is smaller. As a result of these factors, RT-PCR-based tests are expected to dominate the arbovirus testing market over the forecast period.

Geographical Analysis

North America region holds the largest market share of the global arthropod borne viral infections testing market

North America is expected to dominate the worldwide market throughout the projected period, owing to the region's established economy, rising healthcare spending, and high adoption of technologically advanced products. As a result, North America will lead the arbovirus testing market over the projected period.

In addition, organic and inorganic strategies such as mergers and acquisitions and partnerships within key market players will strengthen their product portfolio in the studied market which will drive the market. Also, several product launches in the market will lead to lucrative growth of the market. For instance, in 2021, The Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit is intended to detect immunoglobulin G (IgG) antibodies to qualitatively detect immunoglobulin G (IgG) antibodies SARS-CoV-2 in human serum or plasma, according to Agilent Technologies Inc. Furthermore, advancements in various arthropod-borne viral infections testing devices from established key players, in the United States, are likely to drive the market growth in North America.

Competitive Landscape

The arthropod borne viral infections testing market is a moderately competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Agilent Technologies, ThermoFisher Scientific, NovaTec Immundiagnostica, Euro immune AG, Abbott Laboratories, Bio-Rad, Merck, Acrobiosystems, Biotechne, Elabscience among others.

The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the arthropod borne viral infections testing market globally. For instance, in November 2021, dengue fever diagnostic kits have been developed by Achico, a healthcare technology company based in Switzerland. This new test kit would be based on the company's DNA aptamer technology platform, which effectively diagnoses COVID-19.

Medtronic plc

Overview:

Bio-Techne Corporation is a life science company that develops, manufactures, and sells reagents, tools, and services for research, diagnostics, and bioprocessing.

Product Portfolio:

The Quantikine: Systems for Research and Development The Quantikine ELISA Kits are fully assembled and ready to use. Immunoassays can detect various chemicals, including cytokines, chemokines, growth factors, proteases, and more.

Why Purchase the Report?

Visualize the composition of the global arthropod borne viral infections testing market segmentation by test type, disease type, end user, and region highlighting the key commercial assets and players.

Identify commercial opportunities in the global Arthropod borne Viral Infections Testing Market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of global Arthropod borne Viral Infections Testing Market-level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global arthropod borne viral infections testing market report would provide access to an approximately 40+ market data table, 45+ figures, and in the range of 190 pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Market Segmentation

Global Arthropod borne Viral Infections Testing Market- By Test Type

ELISA-based tests

RT-PCR based tests

Others

Global Arthropod borne Viral Infections Testing Market- By Disease Type

Dengue

Chikungunya

St.Louis Encephalitis

Yellow Fever

California Encephalitis

Eastern Equine Encephalitis

Powassan

West Nile

Zika

Global Arthropod borne Viral Infections Testing Market- By End User

Hospitals

Research Centers

Diagnostic Centers

Others

Global Arthropod borne Viral Infections Testing Market- By Region

North America

Europe

Asia-Pacific

Middle East & Africa

South America

Table of Contents

1. Global Arthropod borne Viral Infections Testing Market- Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Arthropod borne Viral Infections Testing Market- Definition and Overview

3. Global Arthropod borne Viral Infections Testing Market- Executive Summary

  • 3.1. Market Snippet By Test Type
  • 3.2. Market Snippet By Disease Type
  • 3.3. Market Snippet By End User
  • 3.4. Market Snippet by Region

4. Global Arthropod borne Viral Infections Testing Market-Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing government initiatives to lower the risk of arthropod borne viral infections
      • 4.1.1.2. Technological advancements
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of awareness about the infections
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Arthropod borne Viral Infections Testing Market- Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. Global Arthropod borne Viral Infections Testing Market- COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Arthropod borne Viral Infections Testing Market- By Test Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type Segment
    • 7.1.2. Market Attractiveness Index, By Test Type Segment
  • 7.2. ELISA based tests*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. RT-PCR based tests
  • 7.4. Others

8. Global Arthropod borne Viral Infections Testing Market- By Disease Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type Segment
    • 8.1.2. Market Attractiveness Index, By Disease Type Segment
  • 8.2. Dengue*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Chikungunya
  • 8.4. St. Louis Encephalitis
  • 8.5. Yellow Fever
  • 8.6. California Encephalitis
  • 8.7. Eastern Equine Encephalitis
  • 8.8. Powassan
  • 8.9. West Nile
  • 8.10. Zika

9. Global Arthropod borne Viral Infections Testing Market- By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User Segment
  • 9.2. Hospital*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Research Centers
  • 9.4. Diagnostic Centers
  • 9.5. Others

10. Global Arthropod borne Viral Infections Testing Market- By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Global Arthropod borne Viral Infections Testing Market- Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking

12. Global Arthropod borne Viral Infections Testing Market- Company Profiles

  • 12.1. Bio Techne*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Agilent Technologies
  • 12.3. ThermoFisher Scientific
  • 12.4. NovaTecImmundiagnostica
  • 12.5. Euroimmun AG
  • 12.6. Abbott Laboratories
  • 12.7. Bio-Rad
  • 12.8. Merck
  • 12.9. Acrobiosystems
  • 12.10. Biotechne
  • 12.11. Elabscience

LIST NOT EXHAUSTIVE

13. Global Arthropod borne Viral Infections Testing Market- DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us